mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/23/10/2526/13787529/mds075.pdf
Reference64 articles.
1. Optimizing endocrine therapy for breast cancer;Winer;J Clin Oncol,2005
2. Annual hazard rates of recurrence for breast cancer after primary therapy;Saphner;J Clin Oncol,1996
3. Advances in adjuvant endocrine therapy for postmenopausal women;Lin;J Clin Oncol,2008
4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005
5. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009;Goldhirsch;Ann Oncol,2009
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. BOLERO-5: a phase II study of everolimus and exemestane combination in Chinese post-menopausal women with ER + /HER2- advanced breast cancer;Discover Oncology;2024-06-21
2. Amino acids and their roles in tumor immunotherapy of breast cancer;The Journal of Gene Medicine;2023-12-12
3. Statin use in patients with hormone receptor‐positive metastatic breast cancer treated with everolimus and exemestane;Cancer Medicine;2022-10-19
4. Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer;Frontiers in Endocrinology;2021-03-25
5. Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers;The Breast;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3